Ad
related to: bristol-myers squibb- Contact Us
Get In Touch With Our Experts.
We Would Love to Hear From You.
- Development
Comprehensive Integrated Offerings
Bioavailability Enhanced Technology
- Contact Us
Search results
BMS’ Opdivo-Yervoy treatment improves survival in hepatocellular carcinoma trial
Clinical Trials Arena via Yahoo Finance· 1 hour agoBristol Myers Squibb (BMS) has announced findings from the Phase III CheckMate -9DW trial where...
Bristol Myers Squibb Announces Phase 3 Results Of Opdivo/Yervoy Combo In Liver Cancer Patients -...
Benzinga· 21 hours agoOpdivo plus Yervoy combo shows significant survival benefits and higher response rates vs....
Bristol Myers Squibb’s Breyanzi shows promise in B-cell malignancy clinical trials
Clinical Trials Arena via Yahoo Finance· 1 day agoUS-based pharmaceutical company Bristol Myers Squibb (BMS) has published data from three studies in...
Shareholders in Bristol-Myers Squibb (NYSE:BMY) are in the red if they invested a year ago
Simply Wall St. via Yahoo Finance· 1 day agoThe simplest way to benefit from a rising market is to buy an index fund. But if you buy individual...
Rathbones Group PLC Trims Stock Position in Bristol-Myers Squibb (NYSE:BMY)
ETF DAILY NEWS· 1 day agoRathbones Group PLC reduced its stake in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 24.0% in the 4th quarter, according to its most recent 13F filing with the Securities and ...
Why Bristol Myers Squibb (BMY) Outpaced the Stock Market Today
Zacks via Yahoo Finance· 2 days agoThe latest trading session saw Bristol Myers Squibb (BMY) ending at $41.77, denoting a +1.65%...
Bristol-Myers Squibb's Options: A Look at What the Big Money is Thinking - Bristol-Myers Squibb...
Benzinga· 6 days agoLoading... Loading... Deep-pocketed investors have adopted a bearish approach towards Bristol-Myers Squibb BMY , and it's something market players shouldn't ignore. Our tracking of public options ...
Why US Drug Giant Bristol Myers Squibb Stock Trading Up On Monday - Bristol-Myers Squibb (NYSE:BMY)
Benzinga· 2 days agoBristol Myers Squibb & Co BMY announced on Saturday (June 1) results from the Phase 3 KRYSTAL-12...
Bristol Myers Squibb’s Breyanzi gains FDA approval for lymphoma
Pharmaceutical Technology via Yahoo Finance· 5 days agoBristol Myers Squibb (BMS) has received approval from the US Food and Drug Administration for...
Bristol Myers (BMY) Reports Positive Data on Breyanzi, Opdivo (Revised)
Zacks via Yahoo Finance· 6 hours agoBristol Myers (BMY) announces positive data from three studies evaluating CAR T cell therapy...
